| 注册
首页|期刊导航|中国药业|某院慢性阻塞性肺疾病急性加重期全身应用糖皮质激素情况分析

某院慢性阻塞性肺疾病急性加重期全身应用糖皮质激素情况分析

曾海萍 黄健 李珂佳 班立丽 钟娅莉

中国药业Issue(10):66-68,69,4.
中国药业Issue(10):66-68,69,4.

某院慢性阻塞性肺疾病急性加重期全身应用糖皮质激素情况分析

Analysis on Systemic Use Situation of Glucocorticoids for Acute Exacerbation of Chronic Obstructive Pulmonary Diseases in a Hospital during 2012

曾海萍 1黄健 1李珂佳 1班立丽 1钟娅莉2

作者信息

  • 1. 昆明医科大学第二附属医院药学部,云南 昆明 650101
  • 2. 昆明医科大学海源学院,云南 昆明 650101
  • 折叠

摘要

Abstract

Objective To understand the systemic use situation of glucocorticoids in the patients suffering from acute exacerbation of chron-ic obstructive pulmonary diseases(AECOPD)in a hospital to provide reference for clinical safe and rational drug use. Methods 214 cas-es of medical records of AECOPD using systemic glucocorticoids from January to June 2012 were consulted. Then,the variety,administration route,dosage and course of treatment of glucocorticoiuds,drug combination and adverse drug reactions were retrospectively analyzed. Results Among the investigated medical records,the single dosage and treatment course basically accorded with the evaluation standard,but the ADR monitoring in those without diabetes or hypertension should be strengthened. Conclusion Compared with inhaled glucocorticoids,pro-longing the time of intravenous glucocorticoids does not increase the curative effect,but increases the occurrence of systemic ADR.

关键词

糖皮质激素/慢性阻塞性肺疾病急性加重期/合理用药

Key words

glucocorticoids/acute exacerbation of chronic obstructive pulmonary diseases/reasonable use

分类

医药卫生

引用本文复制引用

曾海萍,黄健,李珂佳,班立丽,钟娅莉..某院慢性阻塞性肺疾病急性加重期全身应用糖皮质激素情况分析[J].中国药业,2014,(10):66-68,69,4.

中国药业

1006-4931

访问量0
|
下载量0
段落导航相关论文